# Prerenal AKI in Elderly Patient 1 # Prerenal AKI in Elderly Patient Integrated Case-Based Learning with Module Connections โฑ๏ธ 60-75 min ๐ŸŽฏ Foundation Level ๐Ÿ”— Multi-Module Integration ## Integrated Learning Modules This case integrates content from multiple lecture modules to provide comprehensive learning #### ๐Ÿšจ Primary Module: AKI Recognition & Staging KDIGO criteria, systematic evaluation, emergency recognition #### ๐Ÿ”ฌ Supporting Module: Urinalysis Interpretation Microscopy prioritization, FENa calculation, clinical context #### ๐Ÿ’Š Supporting Module: Drug Nephrotoxicity NSAID-induced AKI, ACE inhibitor effects, prevention strategies #### โšก Supporting Module: Electrolyte Disorders Volume depletion assessment, sodium disorders, acid-base balance #### Quick Access to Related Content: [๐Ÿšจ Complete AKI Module](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html) [๐Ÿ’Š Drug Nephrotoxicity](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/drug-induced/index.html) [๐Ÿ”ฌ Urinalysis Master](https://urinenephrology.org/2025_UDPA_Lectures_Live/urinalysis/index.html) [โšก Electrolyte Disorders](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/index.html) ## Pre-Case Assessment: Test Your Baseline Knowledge Answer these questions before reviewing the case to assess your starting knowledge 1 #### According to KDIGO 2024 guidelines, which of the following BEST defines Stage 2 AKI? A\) Creatinine increase โ‰ฅ0.3 mg/dL within 48 hours B) Creatinine increase to 2.0-2.9ร— baseline within 7 days C) Urine output \<0.3 mL/kg/hr for 24 hours D) Requirement for renal replacement therapy **Correct Answer: B**\ **Learning Point:** Stage 2 AKI is defined by creatinine increase to 2.0-2.9ร— baseline. This is critical for determining monitoring intensity and need for nephrology consultation.\ **๐Ÿ“š Reference:** [KDIGO Staging Section](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html#kdigo-staging) 2 #### In the evaluation of AKI, which laboratory finding MOST reliably differentiates prerenal from intrinsic AKI? A\) BUN:Creatinine ratio \>20:1 B) Fresh urine microscopy findings C) Fractional excretion of sodium (FENa) D) Urine osmolality \>500 mOsm/kg **Correct Answer: B**\ **Learning Point:** Fresh urine microscopy (\<2 hours) is the most reliable differentiator. Hyaline casts suggest prerenal, while muddy brown casts indicate ATN.\ **๐Ÿ“š Reference:** [Urinalysis Interpretation](https://urinenephrology.org/2025_UDPA_Lectures_Live/urinalysis/interpretation.html) 3 #### Which combination of factors creates the highest risk for AKI in elderly patients? A\) ACE inhibitor + thiazide diuretic B) ACE inhibitor + NSAID + volume depletion C) Diabetes + hypertension + age \>80 D) Beta-blocker + calcium channel blocker **Correct Answer: B**\ **Learning Point:** The "triple threat" of ACE inhibitor + NSAID + volume depletion creates synergistic risk for AKI. This combination impairs autoregulation at both afferent and efferent arterioles.\ **๐Ÿ“š Reference:** [Drug-Induced AKI Module](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/drug-induced/index.html) ## Case Presentation **Patient:** 82-year-old woman **Chief Complaint:** Weakness, confusion, and decreased urine output for 3 days **History:** 5-day history of profuse watery diarrhea following gastroenteritis. Poor oral intake. Lives alone, found by neighbor appearing confused and weak. **Past Medical History:** Hypertension, type 2 diabetes, osteoarthritis **Home Medications:** Lisinopril 10mg daily, metformin 1000mg BID, ibuprofen 600mg TID PRN pain ### ๐Ÿค” Initial Clinical Reasoning Questions 4 #### Based on the initial presentation, what is your PRIMARY working diagnosis? A\) Acute tubular necrosis from dehydration B) Prerenal AKI from volume depletion and nephrotoxins C) Acute interstitial nephritis from NSAIDs D) Urinary tract obstruction **Correct Answer: B**\ **Clinical Reasoning:** The combination of volume depletion (diarrhea, poor intake), ACE inhibitor use, and high-dose NSAIDs creates a classic setup for prerenal AKI. The timeline and clinical context strongly support this diagnosis.\ **๐Ÿ“š Learn More:** [AKI Overview & Classification](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html) 5 #### Which medication poses the HIGHEST nephrotoxic risk in this clinical scenario? A\) Lisinopril (ACE inhibitor) B) Ibuprofen (NSAID) C) Metformin D) All medications pose equal risk **Correct Answer: B**\ **Learning Point:** While ACE inhibitors contribute to risk, NSAIDs are the primary culprit in volume-depleted states. NSAIDs block prostaglandin E2, which is essential for afferent arteriolar dilation when volume depleted.\ **๐Ÿ“š Reference:** [NSAID-Induced AKI](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/drug-induced/nsaid-induced.html) ## Physical Examination ### Vital Signs - **Blood Pressure:** 95/60 mmHg (baseline 145/85) - **Heart Rate:** 110 bpm - **Temperature:** 37.8ยฐC (100.0ยฐF) - **Weight:** 62 kg (down 4 kg from baseline) ### Physical Findings - **General:** Appears tired, mild confusion - **HEENT:** Dry mucous membranes, decreased skin turgor - **Cardiovascular:** Tachycardic, no murmurs - **Extremities:** No peripheral edema ### ๐Ÿฉบ Physical Examination Analysis 6 #### The blood pressure drop from 145/85 to 95/60 mmHg in this patient most likely indicates: A\) Improved blood pressure control from medications B) Significant intravascular volume depletion C) Sepsis from gastroenteritis D) Myocardial infarction **Correct Answer: B**\ **Clinical Correlation:** A 50-point systolic drop from baseline, combined with tachycardia and clinical signs of dehydration, indicates significant volume depletion. This supports the prerenal AKI diagnosis.\ **๐Ÿ“š Learn More:** [AKI Overview & Classification](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html) 7 #### This patient presents with tachycardia (HR 110) and hypotension (BP 95/60). What is the BEST initial fluid choice for resuscitation and why? A\) Lactated Ringers - lower chloride content reduces nephrotoxicity risk B) Normal saline - standard isotonic fluid for volume expansion C) Half-normal saline (0.45% NaCl) - gentler fluid replacement D) D5NS with 40 mEq KCl - addresses both volume and electrolyte needs **Correct Answer: A**\ **Clinical Rationale:** Lactated Ringers (LR) is preferred over Normal Saline for volume resuscitation in AKI. LR contains 109 mEq/L chloride vs 154 mEq/L in NS. High chloride loads from NS can cause hyperchloremic metabolic acidosis and may worsen kidney function through afferent arteriolar vasoconstriction. Multiple studies suggest LR is less nephrotoxic than NS in critically ill patients.\ **Other options:** Half-normal saline is hypotonic and inappropriate for hemodynamic instability. D5NS with KCl is contraindicated with hyperkalemia (K+ 5.2 mEq/L). Oral salt pills are inappropriate for acute hypotension.\ **๐Ÿ“š Learn More:** [AKI Management & Fluid Resuscitation](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html) ## Laboratory Data ### Initial Laboratory Values | Parameter | Value | Normal Range | Clinical Significance | |----|----|----|----| | **Serum Creatinine** | 2.8 mg/dL | 0.6-1.2 mg/dL | Baseline 1.1 mg/dL (3 months ago) | | **BUN** | 84 mg/dL | 8-20 mg/dL | BUN:Cr ratio = 30 (suggestive of prerenal) | | **Sodium** | 148 mEq/L | 136-145 mEq/L | Hypernatremia from volume depletion | | **Potassium** | 5.2 mEq/L | 3.5-5.0 mEq/L | Mild hyperkalemia from decreased GFR | | **Chloride** | 118 mEq/L | 98-107 mEq/L | Hypochloremia from diarrheal losses | | **CO2** | 18 mEq/L | 22-28 mEq/L | Metabolic acidosis from diarrhea | ### ๐Ÿ“Š Laboratory Analysis Questions 8 #### Calculate the KDIGO AKI stage for this patient: *Baseline creatinine: 1.1 mg/dL, Current creatinine: 2.8 mg/dL* A\) Stage 1 AKI B) Stage 2 AKI C) Stage 3 AKI D) No AKI present **Correct Answer: B**\ **Calculation:** 2.8 รท 1.1 = 2.5ร— baseline creatinine increase. This meets criteria for Stage 2 AKI (2.0-2.9ร— baseline).\ **๐Ÿ“š Reference:** [Interactive KDIGO Calculator](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html#kdigo) 9 #### The BUN:Creatinine ratio of 30:1 in this patient is elevated. Which factors can cause an elevated BUN:Cr ratio independent of prerenal azotemia? A\) Only prerenal azotemia causes BUN:Cr \>20:1 B) GI bleeding, high protein intake, steroids, and tissue catabolism C) Acute tubular necrosis typically causes high BUN:Cr ratios D) Glomerulonephritis is the most common cause **Correct Answer: B**\ **Clinical Pearl:** While BUN:Cr \>20:1 suggests prerenal azotemia, multiple other factors can elevate this ratio:\ โ€ข **GI bleeding:** Blood proteins are digested โ†’ increased urea production\ โ€ข **High protein intake:** Increased amino acid metabolism โ†’ more urea\ โ€ข **Corticosteroids:** Enhance protein catabolism and urea synthesis\ โ€ข **Tissue catabolism:** Fever, infection, trauma, burns increase protein breakdown\ โ€ข **Dehydration:** Concentrates BUN more than creatinine\ โ€ข **Tetracyclines:** Anti-anabolic effects increase BUN\ \ **Key Teaching:** Always interpret BUN:Cr ratio in clinical context. In this case, the combination of volume depletion history + elevated ratio supports prerenal azotemia, but other causes must be considered in different clinical scenarios.\ **๐Ÿ“š Learn More:** [Creatinine & GFR Interpretation](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/creatinine-gfr.html) 10 #### The combination of hypernatremia (148 mEq/L) and hypochloremia (118 mEq/L) in this patient indicates: A\) Laboratory error B) Hypotonic fluid losses from diarrhea C) Diabetes insipidus D) Syndrome of inappropriate ADH secretion **Correct Answer: B**\ **Learning Point:** Diarrheal fluid has lower sodium and higher chloride than plasma. Loss of hypotonic fluid leads to hypernatremia, while chloride losses exceed sodium losses, causing hypochloremia.\ **๐Ÿ“š Reference:** [Sodium Disorders Module](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/sodium/index.html) ### Urinalysis Results #### Dipstick Results - **Specific Gravity:** 1.030 (high) - **Protein:** Trace - **Blood:** Negative - **Leukocyte Esterase:** Negative - **Nitrites:** Negative #### Microscopy - **RBCs:** 0-2/hpf - **WBCs:** 0-5/hpf - **Casts:** Occasional hyaline casts - **Crystals:** None - **Bacteria:** None ### ๐Ÿ”ฌ Urinalysis Interpretation Questions 11 #### The finding of "occasional hyaline casts" in this patient's urine microscopy is: A\) Pathological and suggests acute tubular necrosis B) Normal finding that supports prerenal AKI C) Indicative of glomerulonephritis D) Sign of urinary tract infection **Correct Answer: B**\ **Learning Point:** Hyaline casts are composed of Tamm-Horsfall protein and can be normal or seen in prerenal states. They distinguish from muddy brown granular casts seen in ATN.\ **๐Ÿ“š Reference:** [Microscopic Examination](https://urinenephrology.org/2025_UDPA_Lectures_Live/urinalysis/microscopic.html) 12 #### The specific gravity of 1.030 in this urinalysis indicates: A\) Intact urinary concentrating ability B) Acute tubular damage C) Chronic kidney disease D) Diabetes insipidus **Correct Answer: A**\ **Learning Point:** High specific gravity (\>1.020) indicates intact concentrating ability, supporting prerenal AKI. In ATN, specific gravity is typically around 1.010-1.012 (isosthenuria).\ **๐Ÿ“š Learn More:** [Urinalysis Dipstick Interpretation](https://urinenephrology.org/2025_UDPA_Lectures_Live/urinalysis/dipstick.html) ## Interactive Diagnostic Timeline Work through the diagnostic process step-by-step by clicking on each time point #### ๐Ÿšจ Emergency Department Arrival (Time 0) Patient presents confused, hypotensive, and tachycardic. What are your immediate priorities? ##### Immediate Priorities: 1. **ABC Assessment:** Ensure airway, breathing, circulation 2. **IV access:** Large bore IV for fluid resuscitation 3. **STAT labs:** BMP, CBC, urinalysis with microscopy 4. **ECG:** Check for hyperkalemia (K+ 5.2 mEq/L) 5. **Bladder scan:** Rule out urinary retention/obstruction **Clinical Pearl:** In elderly patients with AKI, always check for obstruction first - it's the most rapidly reversible cause. #### ๐Ÿ“Š Laboratory Results Available (Time 30 minutes) Labs show creatinine 2.8 mg/dL (baseline 1.1), BUN 84, K+ 5.2. What's your next step? ##### Next Steps Based on Labs: 1. **Confirm AKI:** 2.5ร— baseline increase = Stage 2 AKI 2. **Assess prerenal pattern:** BUN:Cr ratio 30:1 suggests prerenal 3. **Monitor K+:** 5.2 mEq/L - recheck in 4-6 hours, avoid potassium 4. **Order fresh urinalysis:** Essential for differentiation 5. **Calculate FENa:** Will help confirm prerenal vs intrinsic **โš ๏ธ Key Learning:** Don't just look at creatinine - the pattern of abnormalities tells the story! #### ๐Ÿ”ฌ Fresh Urinalysis Results (Time 60 minutes) Urinalysis shows specific gravity 1.030, occasional hyaline casts, no muddy brown casts. What does this tell you? ##### Urinalysis Interpretation: - **Specific gravity 1.030:** Intact concentrating ability โ†’ supports prerenal - **Hyaline casts only:** Normal finding in prerenal states - **Absence of muddy brown casts:** Does not exclude acute tubular injury; consider timing, specimen quality, and the clinical course - **No RBC casts:** Does not exclude glomerulonephritis; assess hematuria, proteinuria, kidney-function trend, and systemic features - **No WBC casts:** Does not exclude acute interstitial nephritis; review medication exposure and other causes of AKI **Conclusion:** Urinalysis strongly supports prerenal AKI diagnosis. **๐Ÿ“š Reference:** [Urinalysis Interpretation Guide](https://urinenephrology.org/2025_UDPA_Lectures_Live/urinalysis/interpretation.html) #### ๐Ÿ’‰ FENa Calculation (Time 90 minutes) Additional urine studies: Urine Na+ 15 mEq/L, Urine Cr 45 mg/dL. Calculate and interpret FENa. ##### FENa Calculation: **Formula:** FENa = (UNa ร— SCr) / (SNa ร— UCr) ร— 100 **Calculation:** (15 ร— 2.8) / (148 ร— 45) ร— 100 = 42/6660 ร— 100 = **0.6%** ##### Interpretation: - **FENa \<1%:** Suggests prerenal AKI - **FENa \>2%:** Suggests intrinsic AKI (ATN) - **FENa 1-2%:** Intermediate/indeterminate **โš ๏ธ Important Caveat:** FENa can be \<1% in some cases of ATN (contrast, sepsis, burns). Clinical context is crucial! **๐Ÿ“š Interactive Tool:** [FENa Calculator with Clinical Caveats](https://urinenephrology.org/2025_UDPA_Lectures_Live/urinalysis/microscopic.html#fena-calculator) ## Treatment Decision Making 13 #### Given the diagnosis of prerenal AKI, what is the MOST important initial treatment intervention? A\) Immediate hemodialysis B) Cautious IV fluid resuscitation C) High-dose loop diuretics D) Vasopressor support **Correct Answer: B**\ **Treatment Rationale:** Prerenal AKI responds to volume repletion. In elderly patients, start with 250-500mL boluses with frequent reassessment to avoid volume overload.\ **๐Ÿ“š Learn More:** [AKI Management & Volume Resuscitation](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html) 14 #### Which medications should be immediately discontinued in this patient? A\) Metformin only B) Lisinopril only C) Lisinopril and ibuprofen D) All medications should be held **Correct Answer: D**\ **Comprehensive Medication Management in AKI:**\ โ€ข **Lisinopril (ACE inhibitor):** Hold - impairs efferent arteriolar autoregulation, can worsen GFR in volume-depleted states\ โ€ข **Ibuprofen (NSAID):** Hold - blocks prostaglandin-mediated afferent arteriolar dilation, highly nephrotoxic in volume depletion\ โ€ข **Metformin:** Hold โ€” per FDA labeling (April 2016 update), metformin is contraindicated when **eGFR \<30 mL/min/1.73mยฒ**, with reassessment of risk/benefit when eGFR is 30โ€“45. The older creatinine-based cutoff (Cr \>1.5 men / \>1.4 women) was officially superseded. In this patient, AKI with rising creatinine 2.8 mg/dL means metformin must be held until renal function recovers and eGFR is reassessed.\ \ **Key Teaching:** In AKI, comprehensive medication review is essential. All potentially nephrotoxic medications should be held, and renally eliminated drugs need dose adjustment. Metformin accumulation with decreased clearance can cause fatal lactic acidosis.\ **๐Ÿ“š Reference:** [Complete AKI Drug Management Guide](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/drug-induced/index.html) 15 #### What is the target urine output for this 62 kg patient during initial resuscitation? A\) \>15 mL/hr B) \>31 mL/hr (0.5 mL/kg/hr) C) \>62 mL/hr (1.0 mL/kg/hr) D) \>124 mL/hr (2.0 mL/kg/hr) **Correct Answer: B**\ **Calculation:** Target urine output = 0.5 mL/kg/hr ร— 62 kg = 31 mL/hr minimum. This is the threshold below which oliguria is defined in AKI staging.\ **๐Ÿ“š Learn More:** [KDIGO AKI Staging Criteria](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html#kdigo-staging) ## Clinical Course & Teaching Points #### Hospital Day 1-6 Summary: - **Day 1-2:** Total 2.5L normal saline over 24 hours, nephrotoxins discontinued - **Day 2:** Creatinine peaked at 3.1 mg/dL, urine output improved to 1.2 mL/kg/hr - **Day 3-5:** Progressive improvement, mental status cleared - **Day 6 Discharge:** Creatinine 1.4 mg/dL (approaching baseline) ### ๐ŸŽฏ Final Assessment Questions 16 #### The fact that creatinine continued to rise to 3.1 mg/dL on Day 2 despite adequate resuscitation indicates: A\) Treatment failure B) Expected lag time in creatinine response C) Development of acute tubular necrosis D) Need for immediate dialysis **Correct Answer: B**\ **Learning Point:** Creatinine may continue to rise for 24-48 hours after adequate resuscitation in prerenal AKI due to the time needed for improved GFR to reflect in serum creatinine levels. Monitor urine output as an earlier indicator of response.\ **๐Ÿ“š Learn More:** [Creatinine Kinetics & GFR](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/creatinine-gfr.html) 17 #### When should ACE inhibitor therapy be resumed in this patient? A\) Immediately upon discharge B) When creatinine returns to baseline C) 1-2 weeks after discharge with stable kidney function D) Never - permanently contraindicated **Correct Answer: C**\ **Management Strategy:** Resume ACE inhibitor gradually once volume status is stable and kidney function has recovered. Start at low dose with close monitoring. The drug isn't permanently contraindicated but requires careful management.\ **๐Ÿ“š Learn More:** [AKI Recovery & Medication Resumption](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html) 18 #### What is the most important long-term prevention strategy for this patient? A\) Permanent discontinuation of all antihypertensive medications B) Patient education about NSAID avoidance and sick day management C) Prophylactic low-dose furosemide D) Monthly creatinine monitoring **Correct Answer: B**\ **Prevention Focus:** Education is key - avoid NSAIDs permanently, hold ACE inhibitors during illnesses with poor oral intake, maintain adequate hydration during GI illnesses, and seek early medical attention for concerning symptoms.\ **๐Ÿ“š Learn More:** [NSAID-Induced AKI Prevention](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/drug-induced/nsaid-induced.html) ## Learning Objectives Assessment Evaluate your mastery of the key learning objectives from this case #### ๐ŸŽฏ Learning Objective 1: KDIGO AKI Staging **Objective:** Apply KDIGO criteria to stage AKI severity and determine appropriate monitoring and management strategies. 19 #### A 70-year-old man has baseline creatinine 1.5 mg/dL. Today his creatinine is 4.8 mg/dL. What KDIGO stage and immediate actions are indicated? A\) Stage 2 AKI - standard monitoring B) Stage 3 AKI - consider nephrology consult and RRT evaluation C) Stage 1 AKI - continue current management D) CKD progression - no acute intervention needed **Correct Answer: B**\ **Rationale:** 4.8 รท 1.5 = 3.2ร— baseline = Stage 3 AKI. Also, creatinine โ‰ฅ4.0 mg/dL automatically qualifies as Stage 3. This requires urgent nephrology consultation and RRT readiness.\ **๐Ÿ“š Master This:** [KDIGO Interactive Calculator](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html#kdigo) #### ๐ŸŽฏ Learning Objective 2: Prerenal vs Intrinsic AKI Differentiation **Objective:** Use clinical presentation, laboratory findings, and urinalysis to distinguish prerenal from intrinsic AKI. 20 #### Which combination of findings MOST strongly suggests intrinsic AKI rather than prerenal? A\) BUN:Cr 25:1, FENa 0.8%, hyaline casts B) BUN:Cr 15:1, FENa 3.2%, muddy brown granular casts C) Urine osmolality 600 mOsm/kg, specific gravity 1.025 D) Volume depletion, hypotension, tachycardia **Correct Answer: B**\ **Key Teaching:** Muddy brown granular casts strongly support acute tubular injury in this clinical setting. FENa and BUN:creatinine ratio are supporting clues whose interpretation depends on medications, CKD, and perfusion; neither independently proves the mechanism.\ **๐Ÿ“š Master This:** [Urinalysis Interpretation Guide](https://urinenephrology.org/2025_UDPA_Lectures_Live/urinalysis/interpretation.html) #### ๐ŸŽฏ Learning Objective 3: Drug-Induced AKI Prevention **Objective:** Identify high-risk medication combinations and implement prevention strategies to reduce AKI risk. 21 #### An 75-year-old woman with CKD (eGFR 45) is prescribed vancomycin and piperacillin-tazobactam for pneumonia. What is the estimated AKI risk and best prevention strategy? A\) Low risk (5%) - no special precautions needed B) High risk (25-40%) - consider alternative antibiotics and AUC-guided dosing C) Moderate risk (10-15%) - standard monitoring sufficient D) Contraindicated combination - must avoid **Correct Answer: B**\ **High-Risk Combination:** Vancomycin + piperacillin-tazobactam has 25-40% AKI risk, especially in elderly with CKD. Consider vancomycin + cefepime or AUC-guided vancomycin dosing with extended-infusion piperacillin-tazobactam.\ **๐Ÿ“š Master This:** [Drug Nephrotoxicity Calculator](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/drug-induced/index.html) ## Integration Challenge: Cross-Module Synthesis These advanced questions require synthesis across multiple knowledge domains 22 #### An 82-year-old woman on lisinopril 20 mg, ibuprofen 400 mg TID for osteoarthritis, and hydrochlorothiazide 25 mg presents with 3 days of diarrhea. Her creatinine is 4.2 mg/dL (baseline 1.1), BUN 68, K+ 5.9 mEq/L, and BP 88/54. Integrating AKI pathophysiology, pharmacology, and electrolyte management โ€” what is the correct sequence of initial interventions? A\) Start IV antibiotics, obtain renal ultrasound, continue all medications B) Emergent dialysis for the elevated creatinine C) Hold lisinopril, ibuprofen, and HCTZ; treat hyperkalemia (calcium gluconate, insulin/D50); isotonic fluid resuscitation; monitor urine output D) Administer furosemide 80 mg IV to increase urine output and lower potassium **Correct Answer: C**\ **Integration Synthesis:** This patient has the classic "triple whammy" (ACE-I + NSAID + volume depletion from diarrhea + diuretic โ€” Lapi BMJ 2013, PMID 23299844). The integration requires: (1) stopping all nephrotoxic agents immediately โ€” the NSAID blocks prostaglandin-mediated afferent arteriolar dilation, the ACE-I blocks efferent arteriolar constriction, and HCTZ worsens volume depletion; (2) **volume resuscitation** as the primary intervention to restore renal perfusion; (3) addressing hyperkalemia. **Calcium gluconate is reserved for ECG changes (peaked T waves, widened QRS, loss of P waves) or K+ \>6.5 mEq/L** per AHA 2020 hyperkalemia consensus โ€” at K+ 5.9 with no ECG changes, treatment is insulin/D50 (intracellular shift) ยฑ a binder (patiromer, Na-zirconium) ยฑ loop diuretic if euvolemic; calcium is added only if ECG changes develop or K+ rises above approximately 6.5. Furosemide would worsen volume depletion in this prerenal patient. Dialysis is premature โ€” most prerenal AKI recovers with intervention. *\[Note added 2026-05-03 โ€” option C as written includes "calcium gluconate" up-front; the more nuanced AHA-aligned approach is to defer calcium gluconate unless ECG changes appear or K+ rises further.\]*\ **๐Ÿ“š Integrate:** [AKI Module](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html) + [NSAID Nephrotoxicity](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/drug-induced/nsaid-induced.html) + [Hyperkalemia Management](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/potassium/hyperkalemia.html) 23 #### After 48 hours of fluid resuscitation, the patient's creatinine improves to 2.8 mg/dL but has not returned to baseline. Her urine microscopy now shows muddy brown granular casts that were not present on admission. What does this finding change about the diagnosis, and how should you adjust the management plan? A\) No change โ€” granular casts are expected in prerenal AKI recovery B) The AKI has progressed from prerenal to acute tubular necrosis (ATN) โ€” prolonged ischemia caused tubular injury. Continue supportive care but counsel the patient that recovery may take 1-3 weeks and adjust medication dosing for reduced GFR C) This indicates glomerulonephritis requiring urgent renal biopsy D) Start IV corticosteroids for acute interstitial nephritis **Correct Answer: B**\ **Integration Synthesis:** This question synthesizes urinalysis interpretation with AKI pathophysiology and pharmacology. Muddy brown granular casts are the hallmark of ATN โ€” indicating that prolonged prerenal ischemia caused structural tubular damage. The initial presentation was prerenal (hyaline casts), but delayed treatment or severity allowed progression to intrinsic AKI. Management shifts from "restore perfusion and recover" to "support through tubular regeneration" โ€” which takes days to weeks. All renally-cleared medications must be dose-adjusted. RBCs/dysmorphic RBCs would suggest glomerulonephritis; WBC casts would suggest AIN.\ **๐Ÿ“š Integrate:** [Urine Microscopy](https://urinenephrology.org/2025_UDPA_Lectures_Live/urinalysis/microscopic.html) + [AKI Staging and Prognosis](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html) + [Creatinine and GFR](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/creatinine-gfr.html) 24 #### Before discharge, you design a "sick day" medication management plan for this patient. Which combination of instructions best integrates AKI prevention, pharmacology, and patient education principles? A\) Stop all medications when ill and restart when feeling better B) Continue all medications but increase fluid intake C) Provide a written "sick day" card: temporarily hold ACE-I, ARB, NSAID, and diuretic during illness with vomiting/diarrhea/fever; maintain oral hydration; seek medical care if unable to keep fluids down or urine output drops; restart medications only after illness resolves and adequate oral intake resumes D) Switch to IV medications at home during illness **Correct Answer: C**\ **Integration Synthesis:** This question operates at the Create level โ€” designing a prevention strategy that integrates pharmacology (which drugs reduce GFR during volume depletion), pathophysiology (why volume depletion + nephrotoxins = AKI), and patient education (actionable instructions patients can follow). The "sick day" concept is an evidence-based AKI prevention strategy increasingly adopted by KDIGO guidelines. It requires the student to synthesize knowledge from the drug, the kidney, and the patient into a practical tool.\ **๐Ÿ“š Integrate:** [Drug-Induced AKI](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/drug-induced/index.html) + [CKD Prevention](https://urinenephrology.org/2025_UDPA_Lectures_Live/ckd/index.html) ## Case Reflection & Multi-Module Integration #### ๐Ÿšจ AKI Module Integration - KDIGO staging application in real patient - Emergency recognition protocols - Systematic diagnostic approach - Prerenal AKI pathophysiology - Furosemide stress test principles [Review Complete AKI Module](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/index.html) #### ๐Ÿ”ฌ Urinalysis Module Integration - Microscopy prioritization over dipstick - Fresh specimen importance (\<2 hours) - FENa calculation and limitations - Hyaline vs granular cast differentiation - Clinical context integration [Review Urinalysis Module](https://urinenephrology.org/2025_UDPA_Lectures_Live/urinalysis/index.html) #### ๐Ÿ’Š Drug Nephrotoxicity Integration - NSAID mechanism in volume depletion - ACE inhibitor effects on autoregulation - "Triple threat" concept application - Risk stratification tools - Prevention strategies implementation [Review Drug Toxicity Module](https://urinenephrology.org/2025_UDPA_Lectures_Live/aki/drug-induced/index.html) #### โšก Electrolyte Module Integration - Volume depletion assessment - Hypernatremia from hypotonic losses - Hypochloremia from diarrhea - Metabolic acidosis evaluation - Potassium monitoring in AKI [Review Electrolyte Module](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/index.html) ### ๐ŸŽฏ Key Integration Concepts This case demonstrates how nephrology knowledge integrates across multiple domains. The systematic approach to AKI requires understanding kidney physiology, pharmacology, fluid and electrolyte balance, and laboratory interpretation. Real clinical excellence comes from synthesizing these different knowledge areas into coherent diagnostic and treatment strategies. #### ๐Ÿ’ก Clinical Integration How different body systems interact during illness and how medications can disrupt normal physiology #### ๐Ÿ” Diagnostic Integration Using multiple data sources (history, exam, labs, urine) to build a complete clinical picture #### ๐Ÿ›ก๏ธ Prevention Integration How understanding pathophysiology leads to effective prevention strategies for future episodes ## ๐Ÿ“ Case Summary & Clinical Pearls This case exemplifies **prerenal AKI** in an elderly patient with the perfect storm of volume depletion, ACE inhibitor use, and NSAID nephrotoxicity. The systematic approach using KDIGO staging, laboratory interpretation, and evidence-based fluid resuscitation led to complete recovery. ### ๐Ÿ”‘ Key Clinical Pearls from This Case: - **The "Triple Threat":** ACE-I + NSAID + Volume Depletion = High AKI Risk - **Microscopy is King:** Fresh urine microscopy differentiates AKI causes better than any other test - **Creatinine Lag:** May continue rising 24-48 hours after successful treatment - don't panic! - **Prevention Focus:** Patient education about sick day management prevents future episodes - **Cautious Resuscitation:** Elderly patients need smaller, more frequent fluid boluses with close monitoring #### ๐ŸŽ“ Ready for the Next Challenge? [โ†’ Case 2: Drug-Induced ATN](https://urinenephrology.org/2025_UDPA_Lectures_Live/cases/case2_enhanced.html) [โ†’ Case 3: Acute Interstitial Nephritis](https://urinenephrology.org/2025_UDPA_Lectures_Live/cases/case3_enhanced.html) [โ†’ Case 4: Severe Hyponatremia](https://urinenephrology.org/2025_UDPA_Lectures_Live/cases/case4_enhanced.html) ## ๐Ÿ“š References 1. **Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S.** Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. *BMJ* 2013;346:e8525. PMID: 23299844. [PubMed](https://pubmed.ncbi.nlm.nih.gov/23299844/) *โ€” the "triple whammy" paper anchoring this case; 487,372 patients; ACE-I/ARB + diuretic + NSAID rate ratio 1.31 (1.12โ€“1.53); 1.82 (1.35โ€“2.46) in first 30 days.* 2. **Khwaja A.** KDIGO clinical practice guidelines for acute kidney injury. *Nephron Clin Pract* 2012;120(4):c179โ€“84. PMID: 22890468. [PubMed](https://pubmed.ncbi.nlm.nih.gov/22890468/) *โ€” canonical KDIGO 2012 AKI staging definitions: Stage 1 = 1.5โ€“1.9ร— baseline, Stage 2 = 2.0โ€“2.9ร— baseline, Stage 3 = โ‰ฅ3.0ร— baseline or Cr โ‰ฅ4.0 mg/dL or RRT.* 3. **Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, Stollings JL, Kumar AB, Hughes CG, Hernandez A, Guillamondegui OD, May AK, Weavind L, Casey JD, Siew ED, Shaw AD, Bernard GR, Rice TW; SMART Investigators.** Balanced crystalloids versus saline in critically ill adults. *N Engl J Med* 2018;378(9):829โ€“39. PMID: 29485925. [PubMed](https://pubmed.ncbi.nlm.nih.gov/29485925/) *โ€” SMART trial; balanced crystalloids reduced major adverse kidney events vs normal saline (14.3% vs 15.4%; OR 0.91, 95% CI 0.84โ€“0.99); supports LR over NS in AKI resuscitation.* 4. **Self WH, Semler MW, Wanderer JP, Wang L, Byrne DW, Collins SP, Slovis CM, Lindsell CJ, Ehrenfeld JM, Siew ED, Shaw AD, Bernard GR, Rice TW; SALT-ED Investigators.** Balanced crystalloids versus saline in noncritically ill adults. *N Engl J Med* 2018;378(9):819โ€“28. PMID: 29485926. [PubMed](https://pubmed.ncbi.nlm.nih.gov/29485926/) *โ€” SALT-ED companion to SMART; same MAKE30 signal in ED-admitted adults; together establishes balanced-crystalloid preference for AKI resuscitation.* 5. **Espinel CH.** The FENa test. Use in the differential diagnosis of acute renal failure. *JAMA* 1976;236(6):579โ€“81. PMID: 947239. [PubMed](https://pubmed.ncbi.nlm.nih.gov/947239/) *โ€” foundational paper introducing fractional excretion of sodium; FENa \<1% = prerenal, \>2% = ATN, with clinical caveats.* 6. **Perazella MA, Coca SG, Kanbay M, Brewster UC, Parikh CR.** Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. *Clin J Am Soc Nephrol* 2008;3(6):1615โ€“9. PMID: 18784207. [PubMed](https://pubmed.ncbi.nlm.nih.gov/18784207/) *โ€” prospective study showing fresh urine microscopy with muddy brown granular casts and renal tubular epithelial cells outperforms FENa for ATN diagnosis; supports microscopy-first approach in this case.* 7. **Luther MK, Timbrook TT, Caffrey AR, Dosa D, Lodise TP, LaPlante KL.** Vancomycin plus piperacillin-tazobactam and acute kidney injury in adults: a systematic review and meta-analysis. *Crit Care Med* 2018;46(1):12โ€“20. PMID: 29088001. [PubMed](https://pubmed.ncbi.nlm.nih.gov/29088001/) *โ€” meta-analysis establishing 25โ€“40% AKI rate with vancomycin + piperacillin-tazobactam vs lower rates with vancomycin alone or vancomycin + cefepime; basis for the high-risk combination teaching point in Q21.* 8. **Schrier RW, Wang W.** Acute renal failure and sepsis. *N Engl J Med* 2004;351(2):159โ€“69. PMID: 15247356. [PubMed](https://pubmed.ncbi.nlm.nih.gov/15247356/) *โ€” mechanism review of prerenal AKI progression to ATN with sustained ischemia; underpins the Q23 teaching point that prolonged prerenal insult drives the prerenal-to-ATN transition seen on follow-up urine microscopy.* 9. **Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ.** Acute kidney injury. *Nat Rev Dis Primers* 2021;7(1):52. PMID: 34267223. [PubMed](https://pubmed.ncbi.nlm.nih.gov/34267223/) *โ€” comprehensive AKI primer; pathophysiology of NSAID-mediated afferent constriction and ACE-I-mediated efferent dilation underlying the "triple whammy" mechanism.* 10. **Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK.** Metformin in patients with type 2 diabetes and kidney disease: a systematic review. *JAMA* 2014;312(24):2668โ€“75. PMID: 25536258. [PubMed](https://pubmed.ncbi.nlm.nih.gov/25536258/) *โ€” evidence base for the 2016 FDA label revision shifting from creatinine-based contraindication to eGFR \<30 mL/min/1.73mยฒ cutoff; supports the Q14 metformin-hold teaching point.* ๐Ÿ“š For Educational Purposes Only - Case-Based Learning Module ยฉ 2025 Andrew Bland MD - All Rights Reserved --- [Website version](https://urinenephrology.org/2025_UDPA_Lectures_Live/cases/case1_enhanced.html) ยท Markdown synchronized October 3, 2026.